CN Patent

CN117999069A — 柠檬酸铁的儿科调配物

Assigned to Keryx Biopharmaceuticals Inc · Expires 2024-05-07 · 2y expired

What this patent protects

本文描述含柠檬酸铁的医药组成物(例如固体口服剂型，诸如片剂)。这里所述的医药组成物可向有需要对象施用。具体地，本文所述的医药组成物可向≤约18岁的对象(例如，约6‑18岁或约12至17岁)施用。

USPTO Abstract

本文描述含柠檬酸铁的医药组成物(例如固体口服剂型，诸如片剂)。这里所述的医药组成物可向有需要对象施用。具体地，本文所述的医药组成物可向≤约18岁的对象(例如，约6‑18岁或约12至17岁)施用。

Drugs covered by this patent

Patent Metadata

Patent number
CN117999069A
Jurisdiction
CN
Classification
—
Expires
2024-05-07
Drug substance claim
No
Drug product claim
No
Assignee
Keryx Biopharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.